Prosecution Insights
Last updated: November 04, 2026

Intramont Technologies Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Intramont Technologies Inc. is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single active matter suggests a highly specific focus for the company's current intellectual property efforts. The presence of 1 pending action indicates that the company is likely prioritizing a particular biotechnological advancement at this time.

The prosecution is overseen by 1 distinct examiner and 1 distinct art unit. This alignment between the examiner and the art unit reflects a concentrated examination process with no technical fragmentation. For the company, this means that the entirety of its active patent strategy is currently subject to the review of a single individual within a single specialized unit. The use of 1 distinct art unit implies a narrow technical scope for the current filing.

LIU, TRACY is the busiest examiner for this portfolio, currently handling 1 busiest examiner pending action. Since this examiner manages the only active case, their individual history and interpretation of the prior art will determine the outcome of the company's current filing. The concentration of 1 busiest examiner pending action under one examiner allows for a focused advocacy strategy but places significant weight on a single relationship.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LIU, TRACY 1 54.3% +26.4%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17437521 PREPARATIONS FOR THE PREVENTION OF ILLNESSES ACQUIRED VIA THE ORAL CAVITY AND PHARYNX LIU, TRACY 27d

Top Art Units

Art UnitApps
1614 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17437521 PREPARATIONS FOR THE PREVENTION OF ILLNESSES ACQUIRED VIA THE ORAL CAVITY AND PHARYNX LIU, TRACY 1614 §103 Final Rejection 27d Pending Sep 09, 2021

Managing Intramont Technologies Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Intramont Technologies Inc. have?

Intramont Technologies Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Intramont Technologies Inc. applications?

Tracy Liu has the most, with 1 of Intramont Technologies Inc.'s pending office actions.

What technology area are Intramont Technologies Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month